Cargando…

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis

An increase in skin-related autoimmune disorders has been reported as an adverse effect of coronavirus disease 2019 (COVID-19) vaccines. We present the case of a 90-year-old Taiwanese female who was newly diagnosed with anti-transcription intermediary factor 1-gamma (anti-TIF1-γ)-positive dermatomyo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chih-Feng, Chen, Wan-Ting, Chen, Yen-Lin, Liu, Feng-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535214/ https://www.ncbi.nlm.nih.gov/pubmed/37763807 http://dx.doi.org/10.3390/medicina59091688

Ejemplares similares

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
por: Lerman, Irina, et al.
Publicado: (2019)

Dermatomyositis with positive anti‐TIF1 gamma antibodies in an adult female: A case report
por: Adhikari, Krishna, et al.
Publicado: (2023)

Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis
por: Li, Xiaomeng, et al.
Publicado: (2022)

Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
por: Ferronato, Marco, et al.
Publicado: (2023)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
por: Parkes, Joanna E., et al.
Publicado: (2018)

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”: A case report
por: Karino, Kohei, et al.
Publicado: (2018)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report
por: Kubeček, Ondřej, et al.
Publicado: (2016)

Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
por: Ono, Ryohei, et al.
Publicado: (2021)

Clinical characteristics of patients with anti-TIF1-γ antibodies
por: Masiak, Anna, et al.
Publicado: (2016)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor
por: Zhang, Hengzhe, et al.
Publicado: (2023)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

A case of dermatomyositis with anti-TIF1γ antibodies revealing isolated para-aortic lymphadenopathy metastatic recurrence of endometrial cancer: A case report
por: Lim, Darosa, et al.
Publicado: (2020)

The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literature
por: Zarkavelis, George, et al.
Publicado: (2020)

ELISA, protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis
por: Selickaja, Sandra, et al.
Publicado: (2022)

Myositis-specific Autoantibodies Reacting to Both Tif1gamma and Mi-2 in a Patient with Juvenile Dermatomyositis
por: TAKEZAKI, Daiki, et al.
Publicado: (2020)

A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-γ Antibody Levels
por: Akagi, Hideko, et al.
Publicado: (2023)

Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
por: Kurushima, Shota, et al.
Publicado: (2017)

Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer
por: Cai, Fengfeng, et al.
Publicado: (2019)

Dynamic Regulation of Tgf-B Signaling by Tif1γ: A Computational Approach
por: Andrieux, Geoffroy, et al.
Publicado: (2012)

Tracker ready for transport at TIF
por: Hoch, Michael
Publicado: (2007)

Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice
por: Mariscal, Anaís, et al.
Publicado: (2021)

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
por: Kessler, Alaina J., et al.
Publicado: (2023)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

OA29 Blotting-based assays under-detected TIF1-gamma and NXP2 autoantibodies compared to immunoprecipitation in Juvenile Dermatomyositis cohorts
por: Nguyen, Huong D, et al.
Publicado: (2022)

Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
por: Zhang, Suo, et al.
Publicado: (2022)

Correction: Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
por: Zhao, Lijuan, et al.
Publicado: (2022)

The CMS Tracker support tube in the TIF.
por: Michael Eppard
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_mikpmrmdnlijiiue8du6lici9g